CTRI/2023/10/058584已完成Unknown
An Open Label Balanced Randomized Single Dose Two Treatment Two Sequence Two Period Two Way Crossover Oral Relative Bioavailability Study Of Curcumin Capsules 200 mg Manufactured By Laila Nutraceuticals Vijayawada India With Curcumin C3 Complex® 1000 mg + Bioperine® (standardized to 95% Piperine) 5 mg Capsules in Healthy Adult Human Male Subjects Under Fasting Conditions - NI
GeneVec0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Normal healthy adult human Male subjects of age between 18-45 years with a Body Mass Index (BMI) ranges between 18.50 kg/m2 to 29.99 kg/m2
- •Subjects who have no evidence of underlying disease during screening and check-in and whose screening is performed within 21 days of check in
- •Subjects whose screening laboratory values are within normal limits or considered by the physician or principal/clinical investigator to be of no clinical significance
- •Healthy as documented by the medical history, physical examination (including but may not be limited to an evaluation of the cardiovascular gastrointestinal respiratory musculoskeletal and central nervous systems) and vital sign assessments
- •Generally healthy as documented by 12-lead electrocardiogram (ECG), X-Ray and clinical laboratory assessments
- •Ex-smokers are defined as someone who has completely stopped smoking for at least the past 03 months
- •Willing to consume Ovo lacto vegetarian diet. (All meals free of turmeric, cumin and black pepper and any related marketed spice mixtures)
- •Willing to comply with all requirements of this study protocol as well as instructed by the study personnel
排除标准
- •Evidence of allergy or known hypersensitivity to Curcumin and Piperine or its inactive ingredients
- •Subjects with hepatic encephalopathy cholestasis myasthenia pre-existing liver disease alcohol abuse existing tinnitus and pre-existing gallbladder disease
- •Any major illness in the last three months or any significant ongoing chronic medical illness
- •Renal or liver impairment
- •History of alcohol addiction or abuse
- •Any disease or condition which might compromise the haemopoeitic, gastrointestinal, renal, hepatic, cardiovascular, Musculoskeletal, respiratory, central nervous system, Or any other body system, presence of Diabetes Mellitus and Psychosis.
- •Consumption of caffeine and /or Xanthine containing products (i.e. coffee, tea, chocolate, and caffeine-containing sodas, colas, etc.) cigarettes and tobacco containing products including tobacco mixed masala, pan, pan masala, gutkha, supari (betel nut) etc.,for at least 48.00 hours prior to check-in and throughout the entire study
- •Consumption of alcohol and its products, grapefruit and/ or its juice and poppy containing foods within 48.00 hours prior to check-in and throughout the entire study
- •Subjects who have taken any prescription medications within 14 days prior to study check-in and throughout the study and any over the counter medicinal products, herbal medications within 07 days prior to check-in and throughout the study
- •Subjects who have taken an unusual diet for whatever reason (e.g. low salt) for 48.00 hours prior to check-in and throughout the study
- •Subject who had participated in any other study within the 90 days of check-in
- •History of difficulty in swallowing, accessibility of veins
- •Positive results for urine screen of drugs of abuse (Marijuana-THC amphetamine-AMP barbiturates-BAR cocaine-COC benzodiazepines-BZD and morphine-MOR) in urine prior to check-in of each period
- •Positive results for alcohol test prior to check-in of each period
- •Any blood donation/excess blood loss within 90 days of check-in
- •Ingestion of any hormonal agent at any time within 14 days prior to start of study check-in
- •Use of hormone replacement therapy for a Period of 06 months prior to dosing
研究者
相似试验
招募中
Unknown
To evaluate the bioequivalence of Relugolix 120 mg tabletsCTRI/2024/07/070477BDR Pharmaceuticals Internationals Pvt Ltd
已完成
Unknown
Comparison of equivalence of two different drug product interms of absorption, distribution, metabolism & excretion in healthy adult human subjectsCTRI/2024/02/062604BDR Pharmaceuticals Internationals Pvt Ltd
尚未招募
Unknown
An Open Label Balanced Randomized Single Dose Two Treatment Two Period Two Sequence Two Way Crossover Oral Bioavailability Study Of Vitamin C Sustained Release Sr Tablets 500 MgCTRI/2024/08/071926utriventia Limited
已完成
不适用
Oral comparative study of melatonin capsulesCTRI/2022/08/044837Dr Shefali Thanawala16
已完成
Unknown
Bioequivalence study of Dydrogesterone tabletsCTRI/2024/01/061471Mankind Pharma Ltd